PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects
Status:
Completed
Trial end date:
2015-07-27
Target enrollment:
Participant gender:
Summary
This is a single ascending dose, open-label study that will evaluate the pharmacokinetics and
safety of the AG-221 compound in normal, healthy volunteer male subjects (both Japanese and
Caucasian).